B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells

Diabetologia

Volumn 56, Issue 1, 2013, Pages 136-146

  Lin, M H ^a   Chou, F C ^a   Yeh, L T ^a   Fu, S H ^b   Chiou, H Y C ^a   Lin, K I ^c   Chang, D M ^d   Sytwu, H K ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

BLIMP 1; CKO; NOD mice; Th1; Th17; Transgenic; Treg; Type 1 diabetes

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL SPECIFICITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; IMMUNOREGULATION; INSULITIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL;

ANIMALS; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; FEMALE; IMMUNOSUPPRESSION; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MICE, TRANSGENIC; PANCREAS; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS; TRANSCRIPTION FACTORS;

EID: 84871611216     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2722-y     Document Type: Article

References (34)

1. Turner CA Jr, Mack DH, Davis MM (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297-306 (Pubitemid 24138626)
2. Lin Y, Wong K, Calame K (1997) Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 276:596-599 (Pubitemid 27193684)
3. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM (2000) BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 13:199-212
4. Lin KI, Angelin-Duclos C, Kuo TC, Calame K (2002) Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol 22:4771-4780 (Pubitemid 34620412)
5. Kallies A, Hawkins ED, Belz GT et al. (2006) Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 7:466-474
6. Martins GA, Cimmino L, Shapiro-Shelef M et al. (2006) Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 7:457-465
7. Cimmino L, Martins GA, Liao J et al. (2008) Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression. J Immunol 181:2338-2347
8. Martins GA, Cimmino L, Liao J, Magnusdottir E, Calame K (2008) Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival. J Exp Med 205:1959-1965
9. Cretney E, Xin A, Shi W et al. (2011) The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol 12:304-311
10. Martins G, Calame K (2008) Regulation and functions of Blimp-1 in T and B lymphocytes. Annu Rev Immunol 26:133-169 (Pubitemid 351600373)
11. Kallies A, Nutt SL (2007) Terminal differentiation of lymphocytes depends on Blimp-1. Curr Opin Immunol 19:156-162 (Pubitemid 46357676)
12. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655-669
13. Ivanov II, McKenzie BS, Zhou L et al. (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126:1121-1133 (Pubitemid 44380299)
14. + regulatory T cells. Nat Immunol 4:330-336 (Pubitemid 36432314)
15. Esensten JH, Lee MR, Glimcher LH, Bluestone JA (2009) T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J Immunol 183:75-82
16. Bending D, de la Pena H, Veldhoen M et al. (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119:565-572
17. Campbell DJ, Koch MA (2011) Phenotypical and functional specialization of FOXP3(+) regulatory T cells. Nat Rev Immunol 11:119-130
18. Abraham C, Cho J (2009) Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15:1090-1100
19. Anderson MS, Bluestone JA (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23:447-485 (Pubitemid 40563177)
20. Sung HH, Juang JH, Lin YC et al. (2004) Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J Exp Med 199:1143-1151 (Pubitemid 38619910)
21. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, Liao J, McHeyzer-Williams MG, Calame K (2003) Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19:607-620 (Pubitemid 37311441)
22. Huang SH, Chu CH, Yu JC et al. (2010) Transgenic expression of haem oxygenase-1 in pancreatic beta cells protects non-obese mice used as a model of diabetes from autoimmune destruction and prolongs graft survival following islet transplantation. Diabetologia 53:2389-2400
23. Lin GJ, Huang SH, Chen YW et al. (2011) Transgenic expression of murine chemokine decoy receptor D6 by islets reveals the role of inflammatory CC chemokines in the development of autoimmune diabetes in NOD mice. Diabetologia 54:1777-1787
24. Shieh SJ, Chou FC, Yu PN et al. (2009) Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes. J Immunol 183:2277-2285
25. Wang YL, Chou FC, Chen SJ, Lin SH, Chang DM, Sytwu HK (2011) Targeting pre-ligand assembly domain of TNFR1 ameliorates autoimmune diseases - an unrevealed role in downregulation of Th17 cells. J Autoimmun 37:160-170
26. Hung JT, Liao JH, Lin YC et al. (2005) Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model. J Autoimmun 25:181-192 (Pubitemid 41654462)
27. Maynard CL, Weaver CT (2009) Intestinal effector T cells in health and disease. Immunity 31:389-400
28. Kwon H, Thierry-Mieg D, Thierry-Mieg J et al. (2009) Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31:941-952
29. Yang XO, Pappu BP, Nurieva R et al. (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29-39
30. Brustle A, Heink S, Huber M et al. (2007) The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 8:958-966 (Pubitemid 47300010)
31. Nikoopour E, Schwartz JA, Huszarik K et al. (2010) Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes. J Immunol 184:4779-4788
32. Ferraro A, Socci C, Stabilini A et al. (2011) Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60:2903-2913
33. Honkanen J, Nieminen JK, Gao R et al. (2010) IL-17 immunity in human type 1 diabetes. J Immunol 185:1959-1967
34. Emamaullee JA, Davis J, Merani S et al. (2009) Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58:1302-1311